The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Biliary Atresia Treatment Market Research Report 2025

Global Biliary Atresia Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1935595

No of Pages : 72

Synopsis
Biliary atresia or extra hepatic ductopenia is an acquired disease of the liver. This disease is characterized by the obliteration of the extra hepatic biliary system which results in obstruction of the bile flow from the liver to gall bladder.
The global Biliary Atresia Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biliary Atresia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biliary Atresia Treatment.
Report Scope
The Biliary Atresia Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biliary Atresia Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biliary Atresia Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Daiichi Sankyo
Eisai
Johnson & Johnson
Novartis
Pfizer
Segment by Type
Drug Treatment
Surgery Treatment
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biliary Atresia Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biliary Atresia Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Drug Treatment
1.2.3 Surgery Treatment
1.3 Market by Application
1.3.1 Global Biliary Atresia Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biliary Atresia Treatment Market Perspective (2019-2030)
2.2 Biliary Atresia Treatment Growth Trends by Region
2.2.1 Global Biliary Atresia Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biliary Atresia Treatment Historic Market Size by Region (2019-2024)
2.2.3 Biliary Atresia Treatment Forecasted Market Size by Region (2025-2030)
2.3 Biliary Atresia Treatment Market Dynamics
2.3.1 Biliary Atresia Treatment Industry Trends
2.3.2 Biliary Atresia Treatment Market Drivers
2.3.3 Biliary Atresia Treatment Market Challenges
2.3.4 Biliary Atresia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biliary Atresia Treatment Players by Revenue
3.1.1 Global Top Biliary Atresia Treatment Players by Revenue (2019-2024)
3.1.2 Global Biliary Atresia Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Biliary Atresia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biliary Atresia Treatment Revenue
3.4 Global Biliary Atresia Treatment Market Concentration Ratio
3.4.1 Global Biliary Atresia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biliary Atresia Treatment Revenue in 2023
3.5 Biliary Atresia Treatment Key Players Head office and Area Served
3.6 Key Players Biliary Atresia Treatment Product Solution and Service
3.7 Date of Enter into Biliary Atresia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biliary Atresia Treatment Breakdown Data by Type
4.1 Global Biliary Atresia Treatment Historic Market Size by Type (2019-2024)
4.2 Global Biliary Atresia Treatment Forecasted Market Size by Type (2025-2030)
5 Biliary Atresia Treatment Breakdown Data by Application
5.1 Global Biliary Atresia Treatment Historic Market Size by Application (2019-2024)
5.2 Global Biliary Atresia Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biliary Atresia Treatment Market Size (2019-2030)
6.2 North America Biliary Atresia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biliary Atresia Treatment Market Size by Country (2019-2024)
6.4 North America Biliary Atresia Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biliary Atresia Treatment Market Size (2019-2030)
7.2 Europe Biliary Atresia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biliary Atresia Treatment Market Size by Country (2019-2024)
7.4 Europe Biliary Atresia Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biliary Atresia Treatment Market Size (2019-2030)
8.2 Asia-Pacific Biliary Atresia Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biliary Atresia Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Biliary Atresia Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biliary Atresia Treatment Market Size (2019-2030)
9.2 Latin America Biliary Atresia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biliary Atresia Treatment Market Size by Country (2019-2024)
9.4 Latin America Biliary Atresia Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biliary Atresia Treatment Market Size (2019-2030)
10.2 Middle East & Africa Biliary Atresia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biliary Atresia Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Biliary Atresia Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Biliary Atresia Treatment Introduction
11.1.4 AstraZeneca Revenue in Biliary Atresia Treatment Business (2019-2024)
11.1.5 AstraZeneca Recent Development
11.2 Daiichi Sankyo
11.2.1 Daiichi Sankyo Company Detail
11.2.2 Daiichi Sankyo Business Overview
11.2.3 Daiichi Sankyo Biliary Atresia Treatment Introduction
11.2.4 Daiichi Sankyo Revenue in Biliary Atresia Treatment Business (2019-2024)
11.2.5 Daiichi Sankyo Recent Development
11.3 Eisai
11.3.1 Eisai Company Detail
11.3.2 Eisai Business Overview
11.3.3 Eisai Biliary Atresia Treatment Introduction
11.3.4 Eisai Revenue in Biliary Atresia Treatment Business (2019-2024)
11.3.5 Eisai Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Biliary Atresia Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Biliary Atresia Treatment Business (2019-2024)
11.4.5 Johnson & Johnson Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Biliary Atresia Treatment Introduction
11.5.4 Novartis Revenue in Biliary Atresia Treatment Business (2019-2024)
11.5.5 Novartis Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Biliary Atresia Treatment Introduction
11.6.4 Pfizer Revenue in Biliary Atresia Treatment Business (2019-2024)
11.6.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Biliary Atresia Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Drug Treatment
Table 3. Key Players of Surgery Treatment
Table 4. Global Biliary Atresia Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Biliary Atresia Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Biliary Atresia Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Biliary Atresia Treatment Market Share by Region (2019-2024)
Table 8. Global Biliary Atresia Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Biliary Atresia Treatment Market Share by Region (2025-2030)
Table 10. Biliary Atresia Treatment Market Trends
Table 11. Biliary Atresia Treatment Market Drivers
Table 12. Biliary Atresia Treatment Market Challenges
Table 13. Biliary Atresia Treatment Market Restraints
Table 14. Global Biliary Atresia Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Biliary Atresia Treatment Market Share by Players (2019-2024)
Table 16. Global Top Biliary Atresia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biliary Atresia Treatment as of 2023)
Table 17. Ranking of Global Top Biliary Atresia Treatment Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Biliary Atresia Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Biliary Atresia Treatment Product Solution and Service
Table 21. Date of Enter into Biliary Atresia Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biliary Atresia Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Biliary Atresia Treatment Revenue Market Share by Type (2019-2024)
Table 25. Global Biliary Atresia Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Biliary Atresia Treatment Revenue Market Share by Type (2025-2030)
Table 27. Global Biliary Atresia Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Biliary Atresia Treatment Revenue Market Share by Application (2019-2024)
Table 29. Global Biliary Atresia Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Biliary Atresia Treatment Revenue Market Share by Application (2025-2030)
Table 31. North America Biliary Atresia Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Biliary Atresia Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Biliary Atresia Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Biliary Atresia Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Biliary Atresia Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Biliary Atresia Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Biliary Atresia Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Biliary Atresia Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Biliary Atresia Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Biliary Atresia Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Biliary Atresia Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Biliary Atresia Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Biliary Atresia Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Biliary Atresia Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Biliary Atresia Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 46. AstraZeneca Company Detail
Table 47. AstraZeneca Business Overview
Table 48. AstraZeneca Biliary Atresia Treatment Product
Table 49. AstraZeneca Revenue in Biliary Atresia Treatment Business (2019-2024) & (US$ Million)
Table 50. AstraZeneca Recent Development
Table 51. Daiichi Sankyo Company Detail
Table 52. Daiichi Sankyo Business Overview
Table 53. Daiichi Sankyo Biliary Atresia Treatment Product
Table 54. Daiichi Sankyo Revenue in Biliary Atresia Treatment Business (2019-2024) & (US$ Million)
Table 55. Daiichi Sankyo Recent Development
Table 56. Eisai Company Detail
Table 57. Eisai Business Overview
Table 58. Eisai Biliary Atresia Treatment Product
Table 59. Eisai Revenue in Biliary Atresia Treatment Business (2019-2024) & (US$ Million)
Table 60. Eisai Recent Development
Table 61. Johnson & Johnson Company Detail
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Biliary Atresia Treatment Product
Table 64. Johnson & Johnson Revenue in Biliary Atresia Treatment Business (2019-2024) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. Novartis Company Detail
Table 67. Novartis Business Overview
Table 68. Novartis Biliary Atresia Treatment Product
Table 69. Novartis Revenue in Biliary Atresia Treatment Business (2019-2024) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Pfizer Company Detail
Table 72. Pfizer Business Overview
Table 73. Pfizer Biliary Atresia Treatment Product
Table 74. Pfizer Revenue in Biliary Atresia Treatment Business (2019-2024) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biliary Atresia Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Biliary Atresia Treatment Market Share by Type: 2023 VS 2030
Figure 3. Drug Treatment Features
Figure 4. Surgery Treatment Features
Figure 5. Global Biliary Atresia Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Biliary Atresia Treatment Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Biliary Atresia Treatment Report Years Considered
Figure 11. Global Biliary Atresia Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Biliary Atresia Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Biliary Atresia Treatment Market Share by Region: 2023 VS 2030
Figure 14. Global Biliary Atresia Treatment Market Share by Players in 2023
Figure 15. Global Top Biliary Atresia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biliary Atresia Treatment as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Biliary Atresia Treatment Revenue in 2023
Figure 17. North America Biliary Atresia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Biliary Atresia Treatment Market Share by Country (2019-2030)
Figure 19. United States Biliary Atresia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Biliary Atresia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Biliary Atresia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Biliary Atresia Treatment Market Share by Country (2019-2030)
Figure 23. Germany Biliary Atresia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Biliary Atresia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Biliary Atresia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Biliary Atresia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Biliary Atresia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Biliary Atresia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Biliary Atresia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Biliary Atresia Treatment Market Share by Region (2019-2030)
Figure 31. China Biliary Atresia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Biliary Atresia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Biliary Atresia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Biliary Atresia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Biliary Atresia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Biliary Atresia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Biliary Atresia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Biliary Atresia Treatment Market Share by Country (2019-2030)
Figure 39. Mexico Biliary Atresia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Biliary Atresia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Biliary Atresia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Biliary Atresia Treatment Market Share by Country (2019-2030)
Figure 43. Turkey Biliary Atresia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Biliary Atresia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. AstraZeneca Revenue Growth Rate in Biliary Atresia Treatment Business (2019-2024)
Figure 46. Daiichi Sankyo Revenue Growth Rate in Biliary Atresia Treatment Business (2019-2024)
Figure 47. Eisai Revenue Growth Rate in Biliary Atresia Treatment Business (2019-2024)
Figure 48. Johnson & Johnson Revenue Growth Rate in Biliary Atresia Treatment Business (2019-2024)
Figure 49. Novartis Revenue Growth Rate in Biliary Atresia Treatment Business (2019-2024)
Figure 50. Pfizer Revenue Growth Rate in Biliary Atresia Treatment Business (2019-2024)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’